This company operates a US FDA-approved topical manufacturing facility, ready to offer a CMO/CDMO model for the US, GCC, EU and ANVISA markets, and is exploring business partners for the distribution and marketing of ANDAs in the US market.

コメントはありません。
評価とコメントを残す